Search alternatives:
significant barriers » significant barrier (Expand Search), significant factors (Expand Search), significant burden (Expand Search)
barriers decrease » larger decrease (Expand Search), barrier disease (Expand Search)
point decrease » point increase (Expand Search)
significant barriers » significant barrier (Expand Search), significant factors (Expand Search), significant burden (Expand Search)
barriers decrease » larger decrease (Expand Search), barrier disease (Expand Search)
point decrease » point increase (Expand Search)
-
1
CKO mice display decreased skin barrier function and perturbed homeostasis.
Published 2025Subjects: -
2
-
3
-
4
Means with standard errors across time points for the outcome of social distance.
Published 2024Subjects: -
5
Means with standard errors across time points for the outcome of intergroup anxiety.
Published 2024Subjects: -
6
Means with standard errors across time points for the outcome of mental health knowledge.
Published 2024Subjects: -
7
-
8
Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.
Published 2025“…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”
-
9
-
10
Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers.
Published 2024“…The values are expressed as the means ± SDs and were analyzed according to the variance of the factorial design. **, *** and ****denote <i>p</i> < 0.01, < 0.001 and < 0.0001, respectively; ns = not significant.…”
-
11
Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations.
Published 2025“…<b>(D)</b> Similarly, U251MG cells showed significantly decreased clonogenic potential upon 100ΜM SHG-44 treatment when compared to 100ΜM cis-platin and the untreated control. …”
-
12
Significant cholesterol genes arranged by day.
Published 2024“…Color represents the P-value; red points have P-values ≤ 0.05, and grey points have P-values > 0.05. …”
-
13
-
14
-
15
-
16
-
17
-
18
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
19
-
20
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: